In this study, we present a novel approach for puerarin to regulate NAFLD by reducing the expression of PPARα, which is regulated by FMO5, helps protect liver cells from fatty acid-induced damage, and ultimately improves NAFLD. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.